The prevalence of olfactory dysfunction and its associated factors in patients with COVID-19 infection: A Hospital-based study

被引:1
|
作者
Hasan, Md Mehedi [1 ]
Tamanna, Naima Ahmed [2 ]
Jamal, Mohammad Nasimul [3 ]
Jamil, Abu Naser Md [1 ]
Uddin, Md Jamal [4 ,5 ]
机构
[1] Ibn Sina Med Coll Hosp, Dept ENT & Head Neck Surg, Dhaka, Bangladesh
[2] Jagannath Univ, Dept Stat, Dhaka, Bangladesh
[3] Sq Hosp Ltd, Dept ENT & Head Neck Surg, Dhaka, Bangladesh
[4] Shahjalal Univ Sci & Technol, Dept Stat, Sylhet, Bangladesh
[5] Daffodil Int Univ, Dept Gen Educ Dev GED, Dhaka, Bangladesh
来源
BANGLADESH JOURNAL OF MEDICAL SCIENCE | 2023年 / 22卷 / 01期
关键词
COVID-19; Anosmia; Olfactory Dysfunction; Factors; Bangladesh; COUNTRIES; SMELL;
D O I
10.3329/bjms.v22i1.63079
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:The coronavirus disease of 2019 (COVID-19) is a global viral pandemic that originated in East Asia (China) and is quickly spreading to every corner of the globe. In Bangladesh, no research has been conducted on olfactory dysfunction in COVID-19 infected patients and its associated factors. We aimed to determine the correlation between olfactory dysfunction (OD), particularly anosmia and COVID-19 infected patients' demographic and clinical characteristics. Methods: We conducted a hospital -based prospective observational study. We collected patients' information, including laboratory-confirmed COVID-19 test results from a COVID dedicated hospital, Square Hospitals Ltd., Dhaka, Bangladesh. We used the Pearson Chi-square test and logistic regression model to assess the associations between demographic and clinical characteristics and OD (i.e. anosmia). Results: Out of 600 COVID-19 positive patients, 38.7% were diagnosed with OD. We found that patients' age, smoking status, cough, dyspnea, sore throat, asthenia, and nausea or vomiting were significantly associated with anosmia. We observed smoking patients were 1.73 times more likely to experience anosmia than non-smoking patients Odd ratio (OR)=1.73, 95% confidence interval (CI) = 1.01-2.98]. Interestingly, our data showed that the risk of developing anosmia was greater in younger patients than in older patients, and this risk decreased as age increased (OR) range for different age groups: 1.26 to 1.08]. In addition, patients who complained of asthenia had a significantly double risk of developing anosmia [OR = 1.96, CI = 1.23-3.06]. Conclusions: Our study shows that 38.7% of patients diagnosed with OD. Patients' age, smoking status, and asthenia are significantly positively associated with anosmia. Since anosmia can be a significant marker for the diagnosis of COVID-19, we suggest regular screening of OD in patients with early symptoms of COVID-19, particularly younger patients, smokers, and who complained of asthenia.
引用
收藏
页码:195 / 204
页数:10
相关论文
共 50 条
  • [1] Prevalence and Prognostic Factors Associated with Early Recovery of Olfactory Dysfunction in COVID-19 Patients
    Kreesaeng, Pattraporn
    Tangbumrungtham, Navarat
    Rachapattayakhom, Ratchaporn
    Roongpuvapaht, Boonsam
    Tanjararak, Kangsadarn
    [J]. ENT-EAR NOSE & THROAT JOURNAL, 2024, 103 (1_SUPPL) : 68S - 75S
  • [2] Olfactory Dysfunction in Healthcare Workers with COVID-19: Prevalence and Associated Factors
    Imene, Kacem
    Mohamed, Kahloul
    Amal, Ghenim
    Mohamed, Ajmi
    Asma, Chouchane
    Asma, Aloui
    Wael, Khalefa
    Kalboussi, H.
    Olfa, El Maalel
    Walid, Naija
    Maher, Maoua
    Nejib, Mrizak
    [J]. RECENT ADVANCES IN INFLAMMATION & ALLERGY DRUG DISCOVERY, 2024, 18 (01): : 67 - 77
  • [3] Prevalence of Low Level of Vitamin D Among COVID-19 Patients and Associated Risk Factors in India - A Hospital-Based Study
    Singh, Shruti
    Nimavat, Nirav
    Singh, Amarjeet Kumar
    Ahmad, Shamshad
    Sinha, Nishi
    [J]. INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2021, 14 : 2523 - 2531
  • [4] Renal dysfunction and prognosis of COVID-19 patients: a hospital-based retrospective cohort study
    Xiang, Hui-Xian
    Fei, Jun
    Xiang, Ying
    Xu, Zheng
    Zheng, Ling
    Li, Xiu-Yong
    Fu, Lin
    Zhao, Hui
    [J]. BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [5] Renal dysfunction and prognosis of COVID-19 patients: a hospital-based retrospective cohort study
    Hui-Xian Xiang
    Jun Fei
    Ying Xiang
    Zheng Xu
    Ling Zheng
    Xiu-Yong Li
    Lin Fu
    Hui Zhao
    [J]. BMC Infectious Diseases, 21
  • [6] Olfactory Dysfunction in a Mexican Population Outside of COVID-19 Pandemic: Prevalence and Associated Factors (the OLFAMEX Study)
    Castillo-Lopez, Irma Yolanda
    Govea-Camacho, Luis Humberto
    Rodriguez-Torres, Ivan Alejandro
    Recio-Macias, Denisse Alejandra
    Alobid, Isam
    Mullol, Joaquim
    [J]. CURRENT ALLERGY AND ASTHMA REPORTS, 2020, 20 (12)
  • [7] Olfactory Dysfunction in a Mexican Population Outside of COVID-19 Pandemic: Prevalence and Associated Factors (the OLFAMEX Study)
    Irma Yolanda Castillo-López
    Luis Humberto Govea-Camacho
    Iván Alejandro Rodríguez-Torres
    Denisse Alejandra Recio-Macías
    Isam Alobid
    Joaquim Mullol
    [J]. Current Allergy and Asthma Reports, 2020, 20
  • [8] Factors Associated With Persisting Olfactory Dysfunction After COVID-19
    Prem, Bernhard
    Liu, David T.
    Boehme, Katharina
    Maurer, Mia T.
    Renner, Bertold
    Mueller, Christian A.
    [J]. CLINICAL OTOLARYNGOLOGY, 2024,
  • [9] Analyzing the Outcomes of COVID-19 Infection on Patients With Comorbidities: Insights From Hospital-Based Study
    Bakthavatchalam, Ramya
    Bakthavatchalam, Sriram
    Ravikoti, Shyamala
    Shanmukham, Bhaskaran
    Reddy, Kotha S.
    Pallavali, Janardhana R.
    Gaur, Archana
    Geetha, Jeganathan
    Varatharajan, Sakthivadivel
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [10] Mechanism of Olfactory Dysfunction in COVID-19 Infection
    Ho, Cheng-Ying
    Salimian, Mohammad
    Holler, Jennifer
    Burke, Allen
    Ames, Heather
    Hegert, Julia
    Drachenberg, Cinthia
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2021, 80 (06): : 587 - 587